Study to investigate the safety profile of AZD4721 after single doses at different dose levels
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Description of the safety profile in terms of Adverse events; blood pressure, heart rate and body temperature; electrocardiograms; clinical chemistry; haematology assessments, including serial blood neutrophil count
Timeframe: From Screening to follow up ( maximum 7 weeks)